Health and Welfare Minister Chen Shih-chung (陳時中) said Thursday that the Taiwan government has asked the American drugmaker Gilead Sciences to reserve doses of its experimental drug Remdesivir for potential use in Taiwan, amid reports that the antiviral medication may be effective in treating the novel coronavirus (2019-nCoV).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Business
Bank SinoPac board approves merger with King's Town Bank
03/27/2026 11:00 PM -
Cross-Strait
-
Business
Taiwan keeps electricity rates unchanged amid global energy uncertainties
03/27/2026 06:40 PM -
Business
Consumer confidence hits 3-year low in March
03/27/2026 06:18 PM -
Society
Ex-KMT lawmaker begins prison sentence in embezzlement case
03/27/2026 05:59 PM